|
1. Biologie
|
|
|
Cryo-EM Images Capture Key Enzyme Tied to Cancer, Aging [NIH Director's Blog]
|
|
|
|
|
|
This
structural biology advance is a critical step toward learning more
about the role of telomerase in cancers, as well as genetic conditions
linked to telomerase deficiencies. It’s also an important milestone in
the quest for drugs targeting telomerase in different ways, perhaps to
slow the growth of cancerous cells or to boost the proliferative
capacity of life-giving adult stem cells.
|
|
|
|
|
|
|
3.1.1 Prévention - Tabac - e-cigs
|
|
|
|
|
3.3 Prévention - Vaccins
|
|
|
Doctors paying for sons to have cancer jab [BBC News]
|
|
|
|
|
|
"Lots
of doctors are having their boys vaccinated because they can afford it,
as are those who are better informed," he said. "But what about those
who can't afford it? Cases of throat cancer are soaring. It's
indefensible.
|
|
|
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
|
|
5. Traitements
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
5.12.1 Immunothérapies - partenariats
|
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
5.12.3 Immunothérapies-combinaisons
|
|
|
|
IDO Appears to Have Wiped Out [In the Pipeline]
|
|
|
|
|
|
So
I think we can say that (at least as currently configured) the
excursion into IDO inhibitors has been a costly mistake. And remember,
as is almost always the case in these things, that it didn’t look like
it was going to be any such thing.
|
|
|
|
|
|
|
|
|
5.12.5 Immunothérapies - Pharma
|
|
|
|
5.12.6 Immunothérapies - AMM
|
|
|
|
U.S. approves Novartis cell therapy for lymphoma [Reuters]
|
|
|
|
|
|
The
new indication puts Kymriah in direct competition with Gilead Sciences’
Yescarta, which was approved by the U.S. Food and Drug Administration
in October for treatment of adults with diffuse large B-cell lymphoma
who have failed to respond to other treatments.
|
|
|
|
|
|
|
|
5.12.8 Immunothérapies - Economie
|
|
|
|
5.2 Pharma
|
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA,...)
|
|
|
|
|
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
Value-Based Pricing for Drugs [JAMA]
|
|
|
|
|
|
The
term value-based pricing has been redefined beyond its original
meaning, and now constitutes shorthand for any change to traditional
payment models for drugs, regardless of the underlying approach to
determining the final price of the product.
|
|
|
|
|
|
|
5.9.1 AACR - sein
|
|
|
|
5.9.4 AACR - poumon
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.1 Observation
|
|
|
|
|
6.3 Associations/Fondations
|
|
|
|
|
|
6.4 Médico-éco
|
|
|
|
6.5 Médecines alternatives
|
|
|
|
6.7.1 IA/bioinformatique
|
|
|
|
6.7.2 Applis
|
|
|
|
|
6.8 Communication
|
|
|
|